Ecor1 Capital Fund Qualified, L.p. - Net Worth and Insider Trading
Ecor1 Capital Fund Qualified, L.p. Net Worth
The estimated net worth of Ecor1 Capital Fund Qualified, L.p. is at least $49 Million dollars as of 2024-11-29. Ecor1 Capital Fund Qualified, L.p. is the 10% Owner of Kura Oncology Inc and owns about 4,408,097 shares of Kura Oncology Inc (KURA) stock worth over $49 Million. Ecor1 Capital Fund Qualified, L.p. is also the 10% Owner of aTyr Pharma Inc and owns about 0 shares of aTyr Pharma Inc (ATYR) stock worth over $0. Details can be seen in Ecor1 Capital Fund Qualified, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ecor1 Capital Fund Qualified, L.p. has not made any transactions after 2018-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ecor1 Capital Fund Qualified, L.p.
Ecor1 Capital Fund Qualified, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ecor1 Capital Fund Qualified, L.p. owns 7 companies in total, including Panacea Acquisition Corp (PANA.U) , Kura Oncology Inc (KURA) , and aTyr Pharma Inc (ATYR) among others .
Insider Ownership Summary of Ecor1 Capital Fund Qualified, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PANA.U | Panacea Acquisition Corp | 2020-07-06 | director & 10 percent owner |
KURA | Kura Oncology Inc | 2018-12-21 | 10 percent owner |
ATYR | aTyr Pharma Inc | 2018-05-16 | 10 percent owner |
2016-06-20 | 10 percent owner | ||
2014-05-22 | other: See Explanation of Responses | ||
2023-02-19 | director | ||
2023-04-28 | director & 10 percent owner |
Ecor1 Capital Fund Qualified, L.p. Latest Holdings Summary
Ecor1 Capital Fund Qualified, L.p. currently owns a total of 2 stocks. Among these stocks, Ecor1 Capital Fund Qualified, L.p. owns 4,408,097 shares of Kura Oncology Inc (KURA) as of December 21, 2018, with a value of $49 Million and a weighting of 100%. Ecor1 Capital Fund Qualified, L.p. also owns 0 shares of aTyr Pharma Inc (ATYR) as of May 16, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Ecor1 Capital Fund Qualified, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KURA | Kura Oncology Inc | 2018-12-21 | 4,408,097 | 11.17 | 49,238,443 |
ATYR | aTyr Pharma Inc | 2018-05-16 | 0 | 3.44 | 0 |
Holding Weightings of Ecor1 Capital Fund Qualified, L.p.
Ecor1 Capital Fund Qualified, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Ecor1 Capital Fund Qualified, L.p. has made a total of 0 transactions in Kura Oncology Inc (KURA) over the past 5 years. The most-recent trade in Kura Oncology Inc is the acquisition of 213,888 shares on December 21, 2018, which cost Ecor1 Capital Fund Qualified, L.p. around $3 Million.
According to the SEC Form 4 filings, Ecor1 Capital Fund Qualified, L.p. has made a total of 0 transactions in aTyr Pharma Inc (ATYR) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the sale of 229,238 shares on May 16, 2018, which brought Ecor1 Capital Fund Qualified, L.p. around $3 Million.
Insider Trading History of Ecor1 Capital Fund Qualified, L.p.
- 1
Ecor1 Capital Fund Qualified, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Ecor1 Capital Fund Qualified, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ecor1 Capital Fund Qualified, L.p. is 4.68%. GuruFocus also compares Ecor1 Capital Fund Qualified, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Ecor1 Capital Fund Qualified, L.p. within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ecor1 Capital Fund Qualified, L.p.'s insider trading performs compared to the benchmark.
Performance of Ecor1 Capital Fund Qualified, L.p.
Ecor1 Capital Fund Qualified, L.p. Ownership Network
Ecor1 Capital Fund Qualified, L.p. Owned Company Details
What does Panacea Acquisition Corp do?
Who are the key executives at Panacea Acquisition Corp?
Ecor1 Capital Fund Qualified, L.p. is the director & 10 percent owner of Panacea Acquisition Corp. Other key executives at Panacea Acquisition Corp include director & 10 percent owner Ecor1 Capital, Llc , director & CEO and Chairman of the Board Oleg Nodelman , and director & 10 percent owner Ecor1 Capital Fund, L.p. .
Panacea Acquisition Corp (PANA.U) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Panacea Acquisition Corp (PANA.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Acquisition Corp (PANA.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Panacea Acquisition Corp (PANA.U)'s detailed insider trading history can be found in Insider Trading Tracker table.
Panacea Acquisition Corp Insider Transactions
Ecor1 Capital Fund Qualified, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Ecor1 Capital Fund Qualified, L.p.. You might contact Ecor1 Capital Fund Qualified, L.p. via mailing address: 357 Tehama Street #3, San Francisco Ca 94103.